Cervical Cancer Trial, Recruiting NCT06500767 Sponsor: University of Turin, Italy Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT06500767
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People attending a Colposcopy service through the Prevenzione Serena screening program, referred because of an abnormal Pap smear result or two consecutive positive HPV test results
  • People whose biopsy result showed a high-grade abnormality (HSIL) in cervical cells
  • People who are able to complete surveys sent by email

Who may not be able to join:

  • People who have previously visited the same Colposcopy service before
  • People who are not enrolled in the Prevenzione Serena screening program
  • People who are currently pregnant
  • People who are unable to complete surveys by email
  • People who have a language barrier that makes communication partially or fully difficult
  • People who have not given their consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Turin, Italy
Registry
ClinicalTrials.gov
Start date
1 June 2022
Est. completion
1 May 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

DASS-21 (Depression Anxiety Stress Scales).; PCL-5 (Posttraumatic Stress Disorder Checklist);; DTS (Dyadic Trust Scale); CDDQ (Cervical Dysplasia Distress Questionnaire); MPI (Match Patient Inventory)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov